Matrine can block the cell cycle of lung cancer A549 cells in G1/G0 phase, upregulate the expression of microRNA (miR)-126, and then downregulate the expression of miR-126 target gene vascular endothelial growth factor (VEGF) and induce apoptosis (An et al., 2016). The gene discussed is VEGFA; the disease is lung carcinoma.